nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control
|
Harper-Wynne, C.L. |
|
2005 |
47 |
2 |
p. 289-290 2 p. |
artikel |
2 |
Anticoagulant drugs increase natural killer cell activity in lung cancer
|
Bobek, V. |
|
2005 |
47 |
2 |
p. 215-223 9 p. |
artikel |
3 |
Bronchioloalveolar carcinoma: a new cancer in Peutz-Jeghers syndrome
|
von Herbay, A. |
|
2005 |
47 |
2 |
p. 283-288 6 p. |
artikel |
4 |
Cytokines and chemokines as predictive markers in non-small cell lung cancer patients with brain metastases
|
Altundag, Ozden |
|
2005 |
47 |
2 |
p. 291-292 2 p. |
artikel |
5 |
Distinct DNA methylation profiles in malignant mesothelioma, lung adenocarcinoma, and non-tumor lung
|
Tsou, Jeffrey A. |
|
2005 |
47 |
2 |
p. 193-204 12 p. |
artikel |
6 |
Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women
|
Ebbert, J.O. |
|
2005 |
47 |
2 |
p. 165-172 8 p. |
artikel |
7 |
Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer
|
Hensing, Thomas A. |
|
2005 |
47 |
2 |
p. 253-259 7 p. |
artikel |
8 |
FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls
|
Vansteenkiste, Johan F. |
|
2005 |
47 |
2 |
p. 151-153 3 p. |
artikel |
9 |
Innovative sequence of docetaxel–gemcitabine based on preclinical data in the treatment of advanced non small cell lung cancer: a phase I study
|
Ibrahim, Toni |
|
2005 |
47 |
2 |
p. 261-267 7 p. |
artikel |
10 |
Large cell neuroendocrine carcinoma of the lung: a comparison with large cell carcinoma with neuroendocrine morphology and small cell carcinoma
|
Peng, Wei-Xia |
|
2005 |
47 |
2 |
p. 225-233 9 p. |
artikel |
11 |
Lung cancer in an urban area in Northern Italy near a coke oven plant
|
Parodi, Stefano |
|
2005 |
47 |
2 |
p. 155-164 10 p. |
artikel |
12 |
Lung carcinoma-associated atypical adenomatoid hyperplasia, squamous cell dysplasia, and chromosome alterations in non-neoplastic bronchial mucosa
|
Kayser, Klaus |
|
2005 |
47 |
2 |
p. 205-214 10 p. |
artikel |
13 |
Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma
|
Fennell, Dean A. |
|
2005 |
47 |
2 |
p. 277-281 5 p. |
artikel |
14 |
Pitfalls in lymph node staging with positron emission tomography in non-small cell lung cancer patients
|
Takamochi, Kazuya |
|
2005 |
47 |
2 |
p. 235-242 8 p. |
artikel |
15 |
pre v: Contents
|
|
|
2005 |
47 |
2 |
p. v- 1 p. |
artikel |
16 |
pre vi : Contents continued
|
|
|
2005 |
47 |
2 |
p. vi- 1 p. |
artikel |
17 |
pre vii: Calendar of Events
|
|
|
2005 |
47 |
2 |
p. vii- 1 p. |
artikel |
18 |
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance
|
Bepler, Gerold |
|
2005 |
47 |
2 |
p. 183-192 10 p. |
artikel |
19 |
Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer
|
Dongiovanni, Diego |
|
2005 |
47 |
2 |
p. 269-275 7 p. |
artikel |
20 |
Surgical mediastinal staging in daily practice
|
Smulders, Sietske A. |
|
2005 |
47 |
2 |
p. 243-251 9 p. |
artikel |
21 |
The female gender has a positive effect on survival independent of background life expectancy following surgical resection of primary non-small cell lung cancer: a study of absolute and relative survival over 15 years
|
BĂĄtevik, Roy |
|
2005 |
47 |
2 |
p. 173-181 9 p. |
artikel |